MedElevator Войти в исследования
← Поиск публикаций

DOI 10.31616/asj.2025.0407

Медицинская библиотека · Asian spine journal · 2026

Association of glucagon-like peptide-1 agonist therapy with postsurgical outcomes following multilevel correction for adult spinal deformity: a propensity score-matched analysis.

D'Amico Cassandra, Jacques Benjamin, Ferdon Robert, Silvestre Jason, Lewis Stephen, Nielsen Christopher, Glaser John, Reitman Charles, Lawrence James, Ravinsky Robert

СтатьяПеревод в очереди

Аннотация

STUDY

DESIGN

Retrospective cohort study.

PURPOSE: This study aimed to examine outcomes in patients with adult spinal deformity (ASD) undergoing deformity correction with and without glucagon-like peptide-1 receptor agonist (GLP-1A) therapy.

OVERVIEW OF LITERATURE: GLP-1As, widely used in diabetes management, have recently been linked to reduced postoperative complications. However, their role in spinal surgery remains underexplored.

METHODS

This multicenter, retrospective cohort study was conducted using the TriNetX Global Collaborative Database (2005-2025) utilizing Current Procedural Terminology and International Classification of Diseases, 10th Revision, codes for patients undergoing spinal deformity correction because of ASD. Patients prescribed GLP-1As within 1 year of surgery were 1:1 propensity-score matched with those who were not using GLP-1As. The cohort was matched according to patient demographics and comorbidities. Surgical outcomes between groups were analyzed at 1- and 2-year intervals. Significance was defined as p <0.05.

RESULTS

At 1 and 2 years following surgery, patients taking GLP-1As exhibited significantly lower odds of pseudoarthrosis, hardware failures, wound dehiscence, infections, thromboembolic events, readmissions, and mortality.

CONCLUSIONS

The findings reveal a significant reduction in the rates of pseudoarthrosis, hardware failure, readmission, and mortality in patients treated with GLP-1As. These results align with the recent literature, pointing to a potential complementary therapy in ASD management. Further studies characterizing the mechanism by which GLP-1As affect postoperative spinal physiology are warranted to assess their utility in optimizing patient outcomes.

Для цитирования: D'Amico Cassandra, Jacques Benjamin, Ferdon Robert, Silvestre Jason, Lewis Stephen, Nielsen Christopher, Glaser John, Reitman Charles, Lawrence James, Ravinsky Robert. Association of glucagon-like peptide-1 agonist therapy with postsurgical outcomes following multilevel correction for adult spinal deformity: a propensity score-matched analysis.. Asian spine journal. 2026. DOI: 10.31616/asj.2025.0407.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.